RED

Hospital visitors don’t need a Vaccine Pass, but do need to scan in, and wear a surgical/medical paper mask. Fabric face coverings are no longer acceptable. See our COVID-19 pages for visiting guidelines, COVID-19 tests and care in the community advice. See www.vaccinatecanterburywestcoast.nz for info about vaccinations.

We are at RED according to the NZ COVID-19 Protection Framework

Last updated:
23 January 2022

The following visitor restrictions are in place for all Canterbury DHB hospitals and health facilities:

  1. All visitors need to scan in using the COVID-19 Tracer App or sign in on arrival and provide their contact details
  2. If you’re using the COVID-19 Tracer App, please ensure Bluetooth tracing is turned on
  3. All visitors must wear a surgical/medical mask. Fabric face coverings are no longer acceptable
  4. All visitors are expected to practice safe physical distancing. You should remain two metres away from people you don’t know
  5. Everyone, including visitors should practise good hand hygiene
  6. Visitors who are unwell should not be entering our facilities.

Patients and visitors should also read the additional more detailed visiting guidelines for each specific hospital.

More COVID-19 information:

Cancer

21 documents.

Medical Oncology and Radiation Oncology referral wait times, staffing and capacity

30/11/2021 REVISED REQUEST: MEDICAL ONCOLOGY and Radiation Oncology -  ONLY Oncology Dept:

  • How many people who have been referred for a first specialist appointment for suspected cancer are waiting over the clinically recommended time frame?
  • What is the CDHB's maximum wait time target for cancer referrals?
  • How many people with diagnosed cancer are waiting to get a specialist appointment for treatment?
  • What is the CDHB doing to address  this?
  • What requests has the CDHB received from staff in the oncology department for additional staff to be recruited?
  • How was this responded to?

Tags

More informationDownload pdf (200KB)

Impact of Covid-19 lockdowns on cervical cancer treatment

The impact of Covid-19 lockdowns and restrictions on cervical cancer screenings and treatments.

Tags

More informationDownload pdf (4MB)

CanRisk Questionnaire

CanRisk questionnaire written by the Canterbury Initiative and adapted by HealthInfo clinical advisers.

Tags

More informationDownload pdf (1MB)

Prostate PSMA Funding

  • Can you advise whether PSMA (Prostate Specific Membrane Antigen) PET-CT is funded by the DHB, or only available privately?
  • If publicly funded, please can you advise whether there are criteria that must be met. For example: For staging of high risk and unfavourable intermediate risk prostate cancer before definitive local therapy. For restaging of PSA recurrence (≥0.2ng/ml).

Tags

More informationDownload pdf (200KB)

Waiting list for surgeries

CDHB - Waiting list GP referrals and waiting list for surgery for the following:

  • Knee Replacement
  • Hip Replacement
  • Hysterectomy
  • Bariatric Surgery
  • Breast Reconstruction

Could you please provide the length of time for patients on the waiting list who was referred in the Canterbury region for the following:

  • CT/MRI/PET Scans
  • Colonoscopy

Could you please provide the average wait time for patients being treated with the following cancers:

  • Lung
  • Bowel
  • Prostate
  • Breast
  • Cervical
  • Skin 

Tags

More informationDownload pdf (400KB)

Bowel Cancer Screening Programme

Canterbury DHB's Readiness report / assessment for the Bowel Cancer Screening Programme.

Tags

More informationDownload pdf (300KB)

Medical Oncology staffing and leave management

Questions around Medical Oncology staffing numbers, leave taken by staff, and type of leave taken by staff.

Tags

More informationDownload pdf (200KB)

Cancer survey oral health

Survey - how a person with cancer has their oral health needs assessed and addressed at each stage of their cancer journey in NZ.

Tags

More informationDownload pdf (2MB)

Medical Radiation Oncology referrals wait times

Total number of patients referred to and seen by Medical Oncology and Radiation Oncology specialities within specified time.

Tags

More informationDownload pdf (300KB)

Outsourcing radiation oncology

Information about your DHB's outsourcing arrangement with the local private radiation oncology provider for delivery of radiation treatment to public patients. Can I please be provided with: 1. total number of treatment courses delivered by tumour type (or palliative if it was palliative intent) between 1 July 2018 and 30 May 2020 in the private provider on your behalf for public patients.

Information on the cost to the tax payer; any or all of the price paid per treatment course delivered, the price per fraction or the total dollar amount paid for all the treatment courses included in your response to the question 1. 3. the number of public patients who received their radiation oncology FSA in private provider on your behalf between 1 July 2018 and 30 May 2020.

Tags

More informationDownload pdf (200KB)

Avastin

Is the drug Avastin used to treat cancers, administered to any patients in the DHB's public Hospitals? If so what is the drug used to treat and how many patients are treated with it?

Tags

More informationDownload pdf (400KB)

Skin cancer

Skin cancer prevention funding and expenditure in the last 10 years.

Tags

More informationDownload pdf (400KB)

Dialysis and chemotherapy patients

Over latest 12 month period. Number of patients treated for dialysis? Number treated with chemotherapy. How many patients have required stays longer than two days in hospital? Broken down by hospital if possible.

Tags

More informationDownload pdf (800KB)

Breast cancer, radiation therapy, and mepitel film

The number of women who received radiation therapy for the most recent full year. Number of women provided with fully funded Mepitel film. Number of women who were not recommended Mepitel film and who were given information about how to purchase from supplier.

Tags

More informationDownload pdf (800KB)

Current wait time regarding prostate cancer treatment

Current waiting time for: Referral from a GP for a prostate cancer initial consultation; for a follow up appointment for a prostate biopsy; for a post biopsy appointment to discuss results and treatment options and for a radical prostatectomy following the post biopsy appointment for persons with a confirmed prostate cancer diagnosis?

Tags

More informationDownload pdf (800KB)

Priority spending and cancer treatment

Priority Spending and cancer treatment. What is the DHB's top ten priorities for spending in the 2019/2020 financial year, and in the past five financial years? Proportion of patients accepted for urgent diagnostic colonoscopy who received the procedure with 14 days. Proportion of patients who received their first treatment within 62 days of being referred with a high suspicion of cancer and a need to be seen within 2 weeks for each of the last five years.

Tags

More informationDownload pdf (800KB)

Prostate cancer wait times

Prostate Cancer: Current wait times: following referral from GP. Follow up appointment for prostate biopsy. Post biopsy appointment to discuss results. Radical prostatectomy following post biopsy appointment.

Tags

More informationDownload pdf (1MB)

Wait time for patients referred with suspicion of cancer.

Average wait time for patients referred with high suspicion of cancer.

Tags

More informationDownload pdf (500KB)

Schedule H budget spent on pharmaceuticals

Please provide information on Schedule H budget spent on pharmaceuticals 2015/16 and 2017/18

Tags

More informationDownload pdf (300KB)

Chemotherapy entitlement

How many rounds of chemotherapy is a patient entitled to under the DHB?

Tags

More informationDownload pdf (400KB)

Surgical waiting lists for various cancers

Surgical waiting lists for cancer and is Canterbury DHB meeting its FCT targets.

Tags

More informationDownload pdf (200KB)

Showing 1-21 of 21 results, page 1 of 1.

Page last updated: 11 January 2022

Is this page useful?